Minerva Biotechnologies

Waltham, United States

Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.

$4.5M raised

Dec 2023

Venture - Series Unknown

Biotechnology Health Care Medical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Minerva Biotechnologies

How much funding has Minerva Biotechnologies raised?

Minerva Biotechnologies has raised $4.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.

Where is Minerva Biotechnologies headquartered?

Minerva Biotechnologies is headquartered in Waltham, United States.

What does Minerva Biotechnologies do?

Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.

What stage is Minerva Biotechnologies at?

Minerva Biotechnologies is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 5, 2023.

MLA

"Minerva Biotechnologies — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/minerva-biotechnologies. Accessed July 2, 2026.

APA

VCBacked. (2023). Minerva Biotechnologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/minerva-biotechnologies

Wikipedia (cite web)

{{cite web |title=Minerva Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/minerva-biotechnologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 5, 2023.